Data as of Dec 09
| -0.40 / -1.05%|
The 9 analysts offering 12-month price forecasts for The Medicines Co have a median target of 39.00, with a high estimate of 45.00 and a low estimate of 36.00. The median estimate represents a +3.17% increase from the last price of 37.80.
The current consensus among 10 polled investment analysts is to Buy stock in The Medicines Co. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.